Summary: S-[ 1 lC]Nomifensine (S-[llC]NMF) is a posi tron-emitting tracer suitable for positron emission tomog raphy, which binds to both dopaminergic and noradren ergic reuptake sites in the striatum and the thalamus. Modelling of the cerebral distribution of this drug has been hampered by the rapid appearance of glucuronide metabolites in the plasma, which do not cross the blood brain barrier. To date, [llC]NMF uptake has simply been expressed as regional versus nonspecific cerebellar activ ity ratios. We have calculated a "free" NMF input curve from red cell activity curves, using the fact that the free drug rapidly equilibrates between red cells and plasma, while glucuronides do not enter red cells. With this free [l1C]NMF input function, all regional cerebral uptake curves could be fitted to a conventional two-compartment model, defining tracer distribution in terms of [1lC]NMF regional volume of distribution. Assuming that the cere-N omifensine (8-amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline hydrogen maleate; NMF) is a psychotropic agent with antidepressant properties. The drug is a potent inhibitor of both noradrenaline and dopamine uptake by presynaptic neuronal terminals. Studies on rat and rabbit striatal membrane preparations suggest that eH]NMF binds to a site on dopaminergic terminals that is associated with the dopamine uptake pump (Dubo covitch and Zahniser, 1985). There is a chiral center
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at position 4 on the tetrahydroisoquinoline ring, and hence two enantiomers. The monoamine uptake in hibition capacity is entirely due to the ( + )-form or S-enantiomer (Schacht and Leven, 1984) , and S NMF is 300 times more potent than the R-form in displacing eH]NMF. Quantitative autoradiographic data have demonstrated that eHlNMF binding to rat caudate-putamen sections is a saturable, high affinity, and sodium-dependent process (Scatton et aI., 1985) .
The racemate of [llC]NMF has been prepared by an N-methylation procedure and used as a tracer for positron emission tomography (PET) (Aquilonius et aI., 1987; Tedroff et aI., 1988) . Specificity of in vivo [ 1 1 C]NMF binding has been shown in animal studies (Aquilonius et aI., 1987; Leenders et aI., 1988) . We have administered the active S-enantiomer of [llC]NMF to both volunteers and patients with aki-netic-rigid syndromes and have compared cerebral S-enantiomer to racemate uptake in controls. We propose a model describing the intracerebral distri bution of [llC]NMF in humans, based on an original correction for plasma metabolites.
METHOD
Subject selection (see Table 1 )
Six healthy age-matched volunteers were studied with active S-[llC]NMF and three with the racemate. Five pa tients with Parkinson's disease (PD) and six patients with multiple-system atrophy (MSA), also known as Shy Drager syndrome, were studied with the active S enantiomer. The mean ages of the control and patient groups did not differ significantly. Hoehn and Yahr clin ical disability scores ranged from 2 to 3 in the PD and from 2 to 4 in the MSA groups. The five patients with PD and two patients with MSA were receiving antiparkinso nian treatment. This treatment consisted of levodopa for all of them, between 400 mg and I.S g per day; one PD patient also took amantadine and deprenyl. This treat ment was stopped the evening before PET and clinical assessment. None of the patient computed tomography or nuclear magnetic resonance scans showed evidence of striatal or thalamic atrophy or infarction. Four of the six MSA patients had cerebellar atrophy present.
Informed consent was obtained from all subjects prior to PET. Permission for these studies was granted by the Ethics Committee, Royal Postgraduate Medical School, Hammersmith Hospital, London, and the Administration of Radioactive Substances Advisory Committee, UK.
Chemistry
The active S-enantiomer and the racemate of [llC] _ NMF were synthesised according to Ulin et al. (1989) . The radiochemical purity was 90% and the specific activ ity at time of administration was \3 ,000-43 ,800 MBq/iJ-mol. The mean ± SD injected dose was 239 ± 89 MBq.
Data acquisition
A whole-body positron emission tomograph (model 931-08/12; CTI Inc., Knoxville, TN, U.S.A.) acquired IS simultaneous transverse planes, 8 direct and 7 cross planes, covering a total axial field of view of 10.8 cm. The transaxial and axial resolution was 7 mm full width at half-maximum (Spinks et aI., 1988 ). An individual head holder was prepared using fast-hardening foam, which expanded around the head of the subject between a pro tective latex sheet and a polystyrene hemicylinder shell (Kearfott et aI., 1984) . The headholder was placed in a solid head support on the scanning couch, and subjects were then carefully positioned using a system of cross laser beams so that the lower plane was parallel to and 10 mm above the orbitomeatal line. A video system of sub tracted images of the face monitored the degree of immo bility throughout the studies. Transmission scans were performed using an external 68Ge source that allowed subsequent emission scans to be corrected for Sll-keV "I-ray attenuation by tissues.
Either the racemate or the active S-enantiomer of [llC]NMF was injected intravenously as a bolus of 10 ml over a period of 2 min, followed by a I-min saline infu sion, using a constant infusion Harvard pump. Twenty one successive measurements of tissue activity were ac quired for 61 min from the start of injection. The acqui sition time per scan was progressively increased from 30 s to S min to obtain sufficient counts in each image (Fig.  1) . For the first 10 min after the start of tracer infusion, blood samples were taken at 20-s to 2.S-min intervals via a radial artery catheter to obtain the plasma peak activity. Arterial samples were then taken every S and then 10 min. Whole-blood and plasma radioactivity were determined for each sample in a well counter cross-calibrated with the tomograph.
A determination of CBF was performed before [ 11 C] _ NMF studies using the C 1 50 2 steady-state technique (Frackowiak et aI., 1980) .
Data analysis
After each time frame of tissue measurement, images of radioactivity distribution in the IS contiguous planes were progressively reconstructed and displayed on a monitor. The 21 time frame measurements obtained during a to mographic study were added to improve the contrast be tween catecholaminergic and noncatecholaminergic cere bral regions for the purpose of defining regions of interest (Fig. 2) . Twenty-one-to 700-pixel (0.84-28 cm 2 ) regions of interest were visually positioned on the composite pic tures so that they encompassed the maximal activity in the examined structure. Left and right thalamus (32 pix els), head of caudate nucleus (21 pixels), and putamen (42 pixels) were selected on two consecutive planes. Mesial frontal (112 pixels) and occipital (700 pixels) cortices were delineated on three consecutive levels, and cerebellum (700 pixels) on one slice. Mean values of regional activity for each specific structure were then calculated for the 21 successive time frames and decay corrected. Values of regions of interest on consecutive planes were appropri ately averaged. Tissue and blood activities were normal ized for the radioactive dose of [llC]NMF injected per unit body weight (expressed as MBq g-I/MBq g-l) and plotted against time. Data were then analysed in terms of ratios of activity in a region of interest compa'Ped with a reference (cerebellum or occipital). To improve the sig naUnoise ratio during the second part of the scan, ratios of averaged activities between 25 and 55 min were calcu lated instead of one individual time frame ratio. Such ra tios are a reflection of specific binding in striatum and thalamus (Aquilonius et aI., 1987) .
A problem with modelling rllC]NMF uptake is the rapid appearance of N-glucuronides in plasma. Hydroxy and hydroxymethoxy metabolites will contribute < 10% of plasma l1C activity at 1 h (Heptner et aI., 1984) . Glu curonides do not enter red cells, while free NMF rapidly equilibrates between plasma and red cells. Based on this fact, we calculated the concentration of tracer in red cells and used a red celUplasma partition coefficient deter mined within the first 300 s after tracer administration to generate a plasma "free" NMF activity time course. This time course was then used as an input function to fit regional cerebral [llC]NMF uptake using conventional compartmental analysis. Tissue activities used in such calculations were an average of left and right values on all appropriate planes of interest, and the values obtained correspond to an average of left and right [l1C]NMF up take.
A Student t test was used to compare R,S-[llC]NMF and S-[IIC]NMF distribution in normal subjects. The dif ferences between S-[IIC]NMF binding in healthy volun teers and in patients were tested using a one-criterion analysis of variance followed by an a posteriori Bonfer roni correction.
RESULTS

Tracer time-activity course
Total plasma radioactivity peaked �2 min after the onset of e lC]NMF infusion and then decreased rapidly over the next 10 min. There was subse quently a slow rise in plasma radioactivity, which plateaued at 30 min (Fig. 3) . Normalised plasma tracer time-activity curves were similar for all sub jects using S-or R,S-[llC]NMF.
Cerebral S-[llC]NMF activity reached a maxi mum 8-15 min after intravenous injection. This maximum activity, in healthy volunteers, was high est in putamen, caudate, and thalamus and lowest in cerebellum and occiput (Fig. 3) . From 25 min on ward, there was a progressive decline in striatal and cerebellar activities, the respective time-activity curves running in parallel. Radioactivity peaked and decreased more rapidly in thalamus than in stri atum, and thalamic activity fell to cerebellar tissue levels after 45 min. After 1 h, the activity in cere bellum and thalamus was similar to that in plasma.
The time course of the racemic tracer tissue ra dioactivity was similar to that obtained with the S- enantiomer, but normalised values were generally lower and differences between striatum and cere bellum were smaller (Fig. 4) .
Ratio analysis
Cerebellum was selected as the nonspecific ref erence tissue in ratio analysis of regional cerebral [llC]NMF uptake. Cerebellar, occipital, and mesial frontal tracer uptakes over 25-55 min were not sig nificantly different between normal subjects and pa tients ( Fig. 3 ; Table 2 ). The average ratio of tha lamic versus cerebellar uptake over 25-55 min was � 1.3 for both patients and controls ( Table 2) .
Ratios of putamen or caudate versus cerebellum tracer uptake were significantly lower using R,S-e'C]NMF rather than the active S-enantiomer in normal subjects (Table 2) . If this ratio minus unity is taken as an index of specific versus non specific e'C]NMF binding, the "specific" uptake of the racemate was 69 and 61 % of that of S-[llC]NMF in putamen and caudate nucleus, re spectively. Figure 5 and Table 2 show that putamen and cau date versus cerebellar tracer uptake ratios were sig nificantly lower in akinetic-rigid patients suffering from PD and MSA than in controls (analysis of vari ance and Bonferroni correction; p < 0.05). In PD "specific" S-[llC]NMF uptake (ratio minus unity) was 40 and 66% of the control values in putamen and caudate, respectively, and similar findings were observed (43 and 60%, respectively) in MSA.
Compartmental analysis
In all subjects ["C]NMF equilibrated between red cells and plasma within 40 s of its administra tion. The red cell versus plasma partition coefficient remained constant up to 300 s following injection of the tracer, and then fell as plasma metabolites that do not permeate red cells formed (Fig. 6) . The value of the initial red cell/plasma partition coefficient was 1.32 ± 0.22 (mean ± SD) in the six healthy volunteers studied with S-e'C]NMF and 1.06 ± 0.18 in those examined with R,S-["C]NMF. It was 1.22 ± 0.19 in PD and 1.05 ± 0.24 in MSA, using S-[llC]NMF. A plasma "free" NMF input function was generated from the red cell activity curves us ing individual red cell/plasma partition coefficients. After peaking, the "free" NMF activity curve showed a continuous decline, without a secondary increase in activity (Fig. 3) . Using the plasma "free" NMF input function, ["C]NMF tissue up take could be fitted satisfactorily to a two compartment model (Figs. 7 and 8) . Table 3 details mean regional cerebral KI and k2 values obtained when cerebral S-and R,S [llC]NMF uptake was fitted using plasma "free" NMF input functions. Normal mean racemic tracer K, values were consistently lower than normal S tracer values, and mean S-["C]NMF K, and k2 val ues were consistently higher in thalamus than in striatum. While KI values were comparable for "nonspecific" regions and striatum, k2 values were markedly lower for striatum. Using the S-tracer, PD and MSA groups had higher striatal k2 values than the normal controls.
Our model defines an equilibrium or partition co efficient (Peq) that relates tracer partition between "specific" and "nonspecific" cerebral compart ments in striatum and thalamus (Fig. 8 , model dia- gram). This Peq representsj2BmaxlKd (Mintun et aI., 1984) for [llC]NMF if only one specific compart ment is present in striatum and thalamus:
where Vd = K l lk2 for the region. Setting Vd (non specific) in striatum and thalamus equal to Vd (cer ebellum), we obtained mean Peq values of 0.9 for putamen and caudate and 0.3 for thalamus in con trol S-e 1 C]NMF studies (Table 4 ; Fig. 9 ). Meanpeq was 30% lower in striatum when the racemate of NMF was used instead of the active S-enantiomer. Mean Peq values were significantly lower in the putamen of patients with PD and MSA (p = 0.05), falling to 40% of the control values in both condi tions. They were also lower in the caudate nucleus (75 and 56% of control values in PD and MSA, re spectively), the reduction in mean MSA caudate Peq reaching significance (p < 0.05). Table 5 shows that mean regional CBF values did not significantly differ between groups. Unidirec tional tracer extraction E can be defined as E = K l /regional CBF. Using this relationship, mean control putamen S-[llC]NMF extraction was 70% and cerebellar extraction was 68%. Putamen and cerebellar R,S-[llC]NMF extractions were both 69%.
DISCUSSION
Ratio analysis of regional cerebral activity curves
Two problems with the use of the ratio approach for analysing specific uptake from regional cerebral PET data are the time dependence of the ratio and the choice of a nonspecific region of reference. The cerebellum is frequently used as a nonspecific re gion. It is almost devoid of dopaminergic projec tions, but receives noradrenergic projections from the locus coeruleus and subcoeruleus. Dopamine and noradrenaline concentrations in the cerebellum are low in postmortem human samples, suggesting that specific uptake of e lC]NMF will be small (Aq uilonius et aI., 1987). In our study, [llC]NMF distribution was found to be similar in cerebellum and occipital regions with both the simple ratio analytical approach and the two-compartment analysis. The use of occiput as a reference gave results similar to those obtained with cerebellum (Table 2 ). This finding is in agreement with the reported regional distribution of catechol aminergic eH]NMF binding to rat brain mem branes. Cerebellar, frontal, and occipital cortex membrane tracer binding were all comparable . Scatton et a1. (1985) have reported that eH]NMF binds chiefly to noradrenergic uptake sites in rat frontal cortex. Our PET scans, however, showed an even distribution of [llC]NMF throughout the cortex. Our frontal time-activity curves were superimposable on those of cerebellum, and the frontal versus cerebellar ra tio values did not differ from unity in any group. These findings are against differential specific [llC]NMF uptake occurring in human frontal cor tex.
Striatal activity peaked at a higher maximum than in noncatecholaminergic tissues. Twenty-five min utes after injection, tracer washout from striatal and nonspecific tissue ran in parallel. The increased stri atal signal results from specific tracer binding to the dopaminergic reuptake sites and is expressed as a larger volume of distribution in the compartmental analysis.
J Cereb Blood Flow Metab. Vol. 10. No.3. 1990 The activity in thalamus peaked at a high maxi mum, but quickly decreased thereafter, reaching cerebellar values after 50 min. CBF values were similar in putamen and thalamus, so that regional blood flow was not responsible for the difference in thalamic and striatal tracer uptake and washout. The difference is likely to result from differential density of dopaminergic and noradrenergic re uptake sites in striatum and thalamus. Noradrener gic innervation of the striatum is far less important than dopaminergic innervation, and the activity in putamen and caudate is due chiefly to [llC]NMF binding to dopaminergic uptake sites (Aquilonius et aI., 1987) . There are few dopaminergic projections to the thalamus, those present arising from the periventricular system, while the anterior nucleus is richly supplied by noradrenergic terminals coming from the locus coeruleus (Lindvall and Bj6rkjund, 1974) . A higher density of lower-affinity receptors in thalamus compared to striatum for e lC]NMF could explain the difference in appearance of the tracer uptake kinetics.
Compartmental analysis of regional cerebral activity curves
The advantage of compartmental compared to ra tio analysis is that time-independent variables de scribing the entire tracer uptake and washout curve are obtained. Unfortunately, to date, NMF com- Values are means ± SD expressed in ml/min/g (KJ) and min -1 (k 2 ). S, active isomer; R,S, racemate; PD, Parkinson's disease; MSA, mUltiple-system atrophy.
partmental analysis has been hampered by the rapid appearance of metabolites in the plasma. These are chiefly glucuronides, nonconjugated metabolites accounting for < 10% of the total metabolites (Lind berg and Syvalahti, 1986). It was calculated that after 15 min the ratio between NMF N-glucuronides and free NMF was 3:1, reaching 25:1 after 2 h. But at neutral pH, free NMF levels are difficult to as say, as glucuronides are highly unstable (Heptner et aI., 1984) . The volume of distribution of the glucu ronides is primarily the plasma, and glucuronide production may explain the second increase in plasma radioactivity observed 10 min after [ 1 lC] NMF administration. Our compartmental model is based on the fact that NMF equilibrates within sec onds between red cells and plasma and that glucu ronides do not enter red cells. Consequently, red cell radioactivity reflects the proportion of "free" exchangeable plasma NMF at any given time. Fig  ure 3 suggests that at 60 min <20% of plasma tracer activity represents free [llC]NMF.
The fact that a two-compartment model ade quately describes tissue tracer uptake in striatum when using a free e lC]NMF arterial input implies that an equilibrium between specific and nonspe cific compartments is rapidly established during tracer uptake and washout across the blood-brain barrier. Figure 10 is a multiple-time graphical anal ysis approach (Patlak and Blasberg, 1985) , showing how [llC]NMF distribution between plasma and tis sue approaches equilibrium. Twenty-five minutes after tracer injection, the horizontal "straight" part of the striatal and cerebellar curves, whose y intercept defines the apparent volume of distribu- Values are means ± SD. expressed in ml blood/ml brain/min. NMF, nomifensine; S, active isomer; R,S, racemate; PD, Parkinson's disease; MSA, multiple-system atrophy.
tion, are parallel, suggesting that the specific and nonspecific compartments in putamen are in equi librium. For ethical reasons, we could not do dis placement studies with pharmacological amounts of cold NMF. Our two-compartment approach en ables us to quantitate specific tracer uptake in terms of a "specific" volume of distribution. If the vol ume of distribution of [llC]NMF in cerebellum is taken as an approximation of the "nonspecific" volume of distribution into brain tissues with dopa minergic (and noradrenergic) terminals, it is possi ble to calculate a partition coefficient between spe cific and nonspecific compartments (see model diagram, Fig. 8) . The use of cerebellum as a non specific compartment is reasonable, for Aquilonius et al. (1987) obtained a striatal/cerebellar [llC]NMF uptake ratio equal to 1.0 in PET studies of rhesus monkeys pretreated with NMF.
The validity of such an approach is indirectly sug gested by the similarity of values of partition coef ficients to a second estimate of specific binding, that is, the regional versus cerebellar ratio of uptake at 25-55 min minus unity (Figs. 5 and 9; Table 6 ).
Racemate and active enantiomer
The specific binding values obtained using the racemate are 60-70% of those obtained with the S enantiomer. Although we observed significant dif ferences in striatal R,S-[llC]NMF binding between volunteers and patients using ratio analysis (K. L. Leenders et aI., in preparation) , the uncertainties concerning the behavior of the nonactive R-enan tiomer prompted us to use the active form as soon as it was available.
Pathological data
Despite the fact that loss of noradrenergic neu rons from the locus coeruleus occurs in both PD and MSA, we were unable to differentiate between S-e'C]NMF binding in thalamus of patients and that of normal subjects.
J Cereb Blood Flow Metab, Vol. 10, No.3, 1990 In healthy volunteers, we found a slightly lower S-e lC]NMF uptake in caudate nucleus than in puta men, in agreement with dopamine measurements in postmortem data (Kish et aI., 1988) . Our finding may, however, also reflect a greater partial volume effect for caudate than for putamen (Mazziotta et aI., 1980) .
The specific binding of the S-[IIC]NMF in puta men of patients suffering from PD and MSA was significantly lower than in age-matched volunteers, mean values using both ratio and compartmental analysis falling to 40% of the control values. Malo teaux et aL (1988) studied binding of another tracer for the dopaminergic reuptake complex eH]GBR 12935 in brain tissue homogenates. They found a 67% decrease of eH]GBR 12935 binding to putam inal dopaminergic uptake sites in postmortem PD brain tissue, a value comparable with our in vivo findings. Postmortem studies on parkinsonian stri atum have shown that dopamine levels are depleted to <20% of control values (Kish et aI., 1988) . To explain the discrepancy between these findings and the 40% control levels of eH]GBR 12935 uptake, Maloteaux et ai. (1988) suggested that some of the remaining binding sites are in fact nonfunctional dopamine transporter sites. This concept is further supported by the report of Hirsch et ai. (1988) of possible mesencephalic nonfunctional neurons that contain neuromelanin in the absence of tyrosine hy droxylase immunoreactivity. Our in vivo, and oth ers' in vitro, data favour the idea that the >80% dopamine depletion measured on postmortem tis sue samples (Kish et aI., 1988 ) is greater than the actual neuronal loss in PD and MSA. It is possible that dopamine depletion is more relevant to the symptomatology of akinetic-rigid syndromes than the loss of catecholaminergic reuptake sites.
In agreement with postmortem data, mean spe cific S-[IlC]NMF uptake in caudate nucleus, as re flected by Pe q ' was less affected than in putamen for the parkinsonian group. The mean caudate Pe q value was significantly depressed for the MSA group. This suggests that some MSA patients have a more diffuse nigral neuronal depletion than PD patients.
Finally, there were not enough data points to make a correlation between the striatal partition co efficient, Pe q ' and the degree of locomotor disability of patients. An inverse relationship has been found between putamen/cerebellar ratios of S- With ["C]NMF as a tracer, in an equilibrium con dition (Fig. 8) , 
